세계의 항균 정형외과 임플란트 시장 보고서(2025년)
Antibacterial Orthopedic Implant Global Market Report 2025
상품코드 : 1764244
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,493,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,386,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,279,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

항균 정형외과 임플란트 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년의 연간 평균 성장률(CAGR)은 9.5%로 성장할 전망이며, 62억 3,000만 달러로 성장이 예측됩니다. 예측 기간 동안 예상되는 성장은 내감염성 임플란트에 대한 수요 증가, 인공관절 치환술 증가, 병원 내 감염에 대한 의식 증가, 감염 관리 강화를 위한 정부의 노력, 은이온 기반 임플란트 이용 확대 등에 기인할 것으로 보입니다. 이 기간에 예상되는 주요 동향으로는 항균 코팅의 기술적 발전, 임플란트 재료 과학의 진보, 임플란트에 나노기술 도입, 생분해성 항균 코팅으로의 이행, 환자 전용 3D 프린팅 임플란트 개발 등이 있습니다.

정형외과 질환의 유병률의 상승은 향후 수년간 항균 정형외과 임플란트 시장의 성장을 견인할 것으로 예측됩니다. 정형외과 질환에는 뼈, 관절, 근육, 힘줄, 인대 등의 근골격계에 영향을 미치는 병세가 포함됩니다. 이 증가의 주요 원인은 고령화이며, 고령자는 시간의 경과에 따른 근골격계의 자연적인 마모나 손상에 기인하는 변형성 관절증, 골다공증, 관절 변성 등의 증상에 걸리기 쉬워집니다. 항균 정형외과 임플란트는 수술 후 감염 위험을 낮추고 조기 회복을 지원하며 임플란트 수술의 장기적인 성공을 높임으로써 이러한 장애를 관리하는 데 중요한 역할을 하고 있습니다. 예를 들어 2023년 3월 영국 정부부문 Office for Health Improvement and Disparities는 2022년 16세 이상 17.6%가 관절염이나 등과 관절의 지속적인 문제 등 장기적인 근골격계(MSK) 질환을 자진 신고했다고 보고했고, 이는 2021년 17.0%에서 증가했습니다. 이처럼 정형외과 질환의 유병률 증가가 항균 정형외과 임플란트 시장 확대에 기여하고 있습니다.

항균 정형외과 임플란트 시장의 주요 기업은 감염 위험을 최소화하고 환자의 예후를 향상시키기 위해 항균 코팅 임플란트와 같은 혁신적인 제품 개발을 선호합니다. 이러한 임플란트는 세균의 증식을 억제하는 항균성 물질로 코팅되어 있기 때문에 감염 가능성을 낮추고 더 나은 치유를 지원하며 외과 수술의 장기적인 성공을 향상시키고 있습니다. 예를 들어 2024년 4월 미국 의료기기 업체인 온코스 서지컬은 항균성 코팅을 한 임플란트에 대해 미국 식품의약국(FDA)으로부터 승인을 받았습니다. 이 이정표를 통해 회사는 정형외과용 임플란트, 특히 종양 수술이나 재수술과 같은 위험한 수술에 있어서 세균 오염과 싸우는 것을 목적으로 한 기술을 제공할 수 있게 되었습니다. 이 자체 코팅은 인비트로 검사에서 99.999%의 살균률을 달성하여 임플란트의 불량, 감염, 절단 등의 심각한 합병증을 예방하는 유망한 솔루션입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

An antibacterial orthopedic implant is a type of medical device utilized in orthopedic surgeries that incorporates antibacterial features to minimize the risk of post-surgical infections. Its mechanism of action usually involves the controlled release of antimicrobial agents from the surface of the implant. These agents either damage bacterial cell walls or inhibit bacterial enzyme functions, thereby preventing bacterial colonization. This approach aids in maintaining a sterile environment around the implant site, supporting quicker recovery and lowering the chances of complications for patients.

The primary categories of antibacterial orthopedic implants include antibacterial bone cement, bone screws, bone plates, joint implants, and spinal implants. Antibacterial bone cement, used to affix implants to bone, contains antimicrobial substances to guard against infection during the healing phase. Frequently used antibacterial agents are silver, chlorhexidine, triclosan, iodine, and vancomycin. These implants are manufactured from a variety of materials, including metals, polymers, ceramics, and composites. They are commonly applied in procedures such as joint replacements, trauma surgeries, spinal operations, and other orthopedic interventions. The main end users of these implants include hospitals, ambulatory surgical centers, clinics, academic and research institutions, and the defense and military sectors.

The antibacterial orthopedic implant market research report is one of a series of new reports from The Business Research Company that provides antibacterial orthopedic implant market statistics, including antibacterial orthopedic implant industry global market size, regional shares, competitors with the antibacterial orthopedic implant market share, antibacterial orthopedic implant market segments, market trends, and opportunities, and any further data you may need to thrive in the antibacterial orthopedic implant industry. This antibacterial orthopedic implant market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antibacterial orthopedic implant market size has grown strongly in recent years. It will grow from $3.95 billion in 2024 to $4.33 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth during the historic period can be credited to several factors, including the rising number of orthopedic injuries, an expanding elderly population, an increased occurrence of post-surgical infections, greater use of trauma fixation techniques, and the growing adoption of minimally invasive orthopedic procedures.

The antibacterial orthopedic implant market size is expected to see strong growth in the next few years. It will grow to $6.23 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The anticipated growth in the forecast period can be attributed to the rising demand for infection-resistant implants, an increasing number of joint replacement surgeries, heightened awareness of hospital-acquired infections, government efforts to enhance infection control, and the growing utilization of silver-ion-based implants. Key trends expected during this period include technological advancements in antibacterial coatings, progress in implant material science, the incorporation of nanotechnology into implants, a transition toward biodegradable antibacterial coatings, and the development of patient-specific 3D-printed implants.

The rising prevalence of orthopedic disorders is anticipated to drive the growth of the antibacterial orthopedic implant market in the coming years. Orthopedic disorders encompass medical conditions that affect the musculoskeletal system, including bones, joints, muscles, tendons, and ligaments. This increase is largely attributed to the aging population, as older individuals are more susceptible to conditions like osteoarthritis, osteoporosis, and joint degeneration resulting from the natural wear and tear of the musculoskeletal system over time. Antibacterial orthopedic implants play a crucial role in managing these disorders by reducing the risk of post-surgical infections, supporting quicker recovery, and enhancing the long-term success of implant procedures. For example, in March 2023, the Office for Health Improvement and Disparities, a UK government department, reported that in 2022, 17.6% of people aged 16 and above self-reported a long-term musculoskeletal (MSK) condition, such as arthritis or ongoing issues with the back or joints-an increase from 17.0% in 2021. Thus, the growing prevalence of orthopedic conditions is contributing to the expansion of the antibacterial orthopedic implant market.

Leading companies in the antibacterial orthopedic implant market are prioritizing the development of innovative products, such as antibacterial coated implants, to minimize infection risks and enhance patient outcomes. These implants are coated with antibacterial substances that inhibit bacterial growth, thereby reducing the likelihood of infection, supporting better healing, and improving the long-term success of surgical procedures. For example, in April 2024, Onkos Surgical Inc., a U.S.-based medical equipment manufacturer, received approval from the U.S. Food & Drug Administration (FDA) for its antibacterial coated implants. This milestone enables the company to offer a technology aimed at combating bacterial contamination in orthopedic implants, particularly in high-risk procedures like tumor and revision surgeries. The proprietary coating has demonstrated bactericidal properties, achieving a 99.999% kill rate in in-vitro testing, presenting a promising solution to prevent serious complications such as implant failure, infection, and amputation.

In May 2023, Zimmer Biomet Holdings, Inc., a U.S.-based medical device company, acquired OSSIS for an undisclosed amount. This acquisition is intended to enhance Zimmer Biomet's hip reconstruction product portfolio by incorporating OSSIS's expertise in personalized 3D-printed implants and complex hip replacement solutions, thereby driving innovation and improving patient outcomes. OSSIS Corporation, based in New Zealand, specializes in the development of customized 3D-printed antibacterial orthopedic implants.

Major players in the antibacterial orthopedic implant market are Stryker Corporation, Zimmer Biomet Holdings Inc., Smith & Nephew plc, DePuy Synthes Inc., Exactech Inc., MicroPort Orthopedics Inc., Tegra Medical LLC, Implantcast GmbH, aap Implantate AG, Accentus Medical Ltd., Onkos Surgical Inc., BONESUPPORT AB, Heraeus Medical GmbH, Promimic AB, Silver Bullet Therapeutics Inc., TEKNIMED S.A.S., BioMedtrix LLC, BioGate AG, Tecres S.p.A., Kyocera Medical Technologies Inc.

North America was the largest region in the antibacterial orthopedic implant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the antibacterial orthopedic implant market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antibacterial orthopedic implant market consists of sales of shoulder prosthesis, antibacterial prosthetic implants, antibacterial trauma implants, antibacterial bone grafts, antibacterial biodegradable implants, and antibacterial arthroplasty implants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antibacterial Orthopedic Implant Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antibacterial orthopedic implant market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for antibacterial orthopedic implant ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antibacterial orthopedic implant market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Antibacterial Orthopedic Implant Market Characteristics

3. Antibacterial Orthopedic Implant Market Trends And Strategies

4. Antibacterial Orthopedic Implant Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Antibacterial Orthopedic Implant Growth Analysis And Strategic Analysis Framework

6. Antibacterial Orthopedic Implant Market Segmentation

7. Antibacterial Orthopedic Implant Market Regional And Country Analysis

8. Asia-Pacific Antibacterial Orthopedic Implant Market

9. China Antibacterial Orthopedic Implant Market

10. India Antibacterial Orthopedic Implant Market

11. Japan Antibacterial Orthopedic Implant Market

12. Australia Antibacterial Orthopedic Implant Market

13. Indonesia Antibacterial Orthopedic Implant Market

14. South Korea Antibacterial Orthopedic Implant Market

15. Western Europe Antibacterial Orthopedic Implant Market

16. UK Antibacterial Orthopedic Implant Market

17. Germany Antibacterial Orthopedic Implant Market

18. France Antibacterial Orthopedic Implant Market

19. Italy Antibacterial Orthopedic Implant Market

20. Spain Antibacterial Orthopedic Implant Market

21. Eastern Europe Antibacterial Orthopedic Implant Market

22. Russia Antibacterial Orthopedic Implant Market

23. North America Antibacterial Orthopedic Implant Market

24. USA Antibacterial Orthopedic Implant Market

25. Canada Antibacterial Orthopedic Implant Market

26. South America Antibacterial Orthopedic Implant Market

27. Brazil Antibacterial Orthopedic Implant Market

28. Middle East Antibacterial Orthopedic Implant Market

29. Africa Antibacterial Orthopedic Implant Market

30. Antibacterial Orthopedic Implant Market Competitive Landscape And Company Profiles

31. Antibacterial Orthopedic Implant Market Other Major And Innovative Companies

32. Global Antibacterial Orthopedic Implant Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Antibacterial Orthopedic Implant Market

34. Recent Developments In The Antibacterial Orthopedic Implant Market

35. Antibacterial Orthopedic Implant Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기